Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung Cancer

ChangLiang Luo, Zhongyuan Lin, Fangfang Huang, Leping Ning, Yulin Yuan Department of Clinical Laboratory, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530021, People’s Republic of ChinaCorrespondence: Leping Ning; Yulin Yuan, Department of Clinical Laboratory, The Peo...

Full description

Saved in:
Bibliographic Details
Main Authors: Luo C, Lin Z, Huang F, Ning L, Yuan Y
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/tumor-educated-platelets-lncrna-stard4-as1-and-eloa-as1-as-potential-n-peer-reviewed-fulltext-article-CMAR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841558962209554432
author Luo C
Lin Z
Huang F
Ning L
Yuan Y
author_facet Luo C
Lin Z
Huang F
Ning L
Yuan Y
author_sort Luo C
collection DOAJ
description ChangLiang Luo, Zhongyuan Lin, Fangfang Huang, Leping Ning, Yulin Yuan Department of Clinical Laboratory, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530021, People’s Republic of ChinaCorrespondence: Leping Ning; Yulin Yuan, Department of Clinical Laboratory, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People’s Republic of China, Email ningleping@126.com; yuanyulin@126.comPurpose: (Tumor-educated platelets) TEPs have emerged as active players in all steps of tumorigenesis, confrontation of platelets with tumor cells via transfer of tumor-associated biomolecules and results in the sequestration of such biomolecules. The current study was aimed to examine whether TEPs lncRNA-STARD4-AS1 and ELOA-AS1 might be potential biomarkers for NSCLC.Materials and Methods: TEPs were obtained by low-speed centrifugation. Quantitative real-time PCR was used to determine the expression level of TEPs-STARD4-AS1, ELOA-AS1 in the training cohort and the validation cohort. ROC curve was generated to evaluate their diagnostic value. Correlations between TEPs-STARD4-AS1, ELOA-AS1 and clinical parameters were further analyzed.Results: Our results showed that the level of TEPs-STARD4-AS1 and ELOA-AS1 significantly upregulated in patients with NSCLC compared with healthy controls in the two cohorts. By ROC analysis, we found that TEPs-STARD4-AS1, ELOA-AS1 could offer valuable diagnostic performance for NSCLC patients (AUCSTARD4-AS1 = 0.800/0.774, and AUCELOA-AS1 = 0.754/0.718 for diagnosing adenocarcinoma and squamous cell carcinoma cases from controls, respectively). The combination of TEP-STARD4-AS1 and ELOA-AS1 improved the diagnostic efficiency of NSCLC. Clinicopathological analysis further revealed that TEPs-STARD4-AS1 level significantly correlated with tumor-node-metastasis (TNM) stage (p = 0.011), while TEPs-ELOA-AS1 expression significantly correlated with tumor-node-metastasis (TNM) stage and (p = 0.019) distant metastasis (p = 0.004).Conclusion: Our data suggested that TEPs-STARD4-AS1 and ELOA-AS1 are promising non-invasive circulating diagnostic markers for NSCLC.Keywords: tumor-educated platelets, STARD4-AS1, ELOA-AS1, diagnosis, NSCLC
format Article
id doaj-art-24c118b113db41b78d657b2e9982a517
institution Kabale University
issn 1179-1322
language English
publishDate 2025-01-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj-art-24c118b113db41b78d657b2e9982a5172025-01-05T16:36:04ZengDove Medical PressCancer Management and Research1179-13222025-01-01Volume 171998919Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung CancerLuo CLin ZHuang FNing LYuan YChangLiang Luo, Zhongyuan Lin, Fangfang Huang, Leping Ning, Yulin Yuan Department of Clinical Laboratory, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530021, People’s Republic of ChinaCorrespondence: Leping Ning; Yulin Yuan, Department of Clinical Laboratory, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People’s Republic of China, Email ningleping@126.com; yuanyulin@126.comPurpose: (Tumor-educated platelets) TEPs have emerged as active players in all steps of tumorigenesis, confrontation of platelets with tumor cells via transfer of tumor-associated biomolecules and results in the sequestration of such biomolecules. The current study was aimed to examine whether TEPs lncRNA-STARD4-AS1 and ELOA-AS1 might be potential biomarkers for NSCLC.Materials and Methods: TEPs were obtained by low-speed centrifugation. Quantitative real-time PCR was used to determine the expression level of TEPs-STARD4-AS1, ELOA-AS1 in the training cohort and the validation cohort. ROC curve was generated to evaluate their diagnostic value. Correlations between TEPs-STARD4-AS1, ELOA-AS1 and clinical parameters were further analyzed.Results: Our results showed that the level of TEPs-STARD4-AS1 and ELOA-AS1 significantly upregulated in patients with NSCLC compared with healthy controls in the two cohorts. By ROC analysis, we found that TEPs-STARD4-AS1, ELOA-AS1 could offer valuable diagnostic performance for NSCLC patients (AUCSTARD4-AS1 = 0.800/0.774, and AUCELOA-AS1 = 0.754/0.718 for diagnosing adenocarcinoma and squamous cell carcinoma cases from controls, respectively). The combination of TEP-STARD4-AS1 and ELOA-AS1 improved the diagnostic efficiency of NSCLC. Clinicopathological analysis further revealed that TEPs-STARD4-AS1 level significantly correlated with tumor-node-metastasis (TNM) stage (p = 0.011), while TEPs-ELOA-AS1 expression significantly correlated with tumor-node-metastasis (TNM) stage and (p = 0.019) distant metastasis (p = 0.004).Conclusion: Our data suggested that TEPs-STARD4-AS1 and ELOA-AS1 are promising non-invasive circulating diagnostic markers for NSCLC.Keywords: tumor-educated platelets, STARD4-AS1, ELOA-AS1, diagnosis, NSCLChttps://www.dovepress.com/tumor-educated-platelets-lncrna-stard4-as1-and-eloa-as1-as-potential-n-peer-reviewed-fulltext-article-CMARtumor-educated plateletsstard4-as1eloa-as1diagnosisnsclc.
spellingShingle Luo C
Lin Z
Huang F
Ning L
Yuan Y
Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung Cancer
Cancer Management and Research
tumor-educated platelets
stard4-as1
eloa-as1
diagnosis
nsclc.
title Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung Cancer
title_full Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung Cancer
title_fullStr Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung Cancer
title_full_unstemmed Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung Cancer
title_short Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung Cancer
title_sort tumor educated platelets lncrna stard4 as1 and eloa as1 as potential novel biomarkers for the early diagnosis of non small cell lung cancer
topic tumor-educated platelets
stard4-as1
eloa-as1
diagnosis
nsclc.
url https://www.dovepress.com/tumor-educated-platelets-lncrna-stard4-as1-and-eloa-as1-as-potential-n-peer-reviewed-fulltext-article-CMAR
work_keys_str_mv AT luoc tumoreducatedplateletslncrnastard4as1andeloaas1aspotentialnovelbiomarkersfortheearlydiagnosisofnonsmallcelllungcancer
AT linz tumoreducatedplateletslncrnastard4as1andeloaas1aspotentialnovelbiomarkersfortheearlydiagnosisofnonsmallcelllungcancer
AT huangf tumoreducatedplateletslncrnastard4as1andeloaas1aspotentialnovelbiomarkersfortheearlydiagnosisofnonsmallcelllungcancer
AT ningl tumoreducatedplateletslncrnastard4as1andeloaas1aspotentialnovelbiomarkersfortheearlydiagnosisofnonsmallcelllungcancer
AT yuany tumoreducatedplateletslncrnastard4as1andeloaas1aspotentialnovelbiomarkersfortheearlydiagnosisofnonsmallcelllungcancer